Alcala

What Alcala does

Alcala Labs is a San Diego-based clinical laboratory founded in 2010 that provides toxicology, pharmacogenetics, infectious disease, and blood wellness testing, with a primary focus on drug rehabilitation facilities, pain management practices, and psychiatry practices. The company's core technical platform is liquid chromatography/mass spectrometry (LC-MS) used as a 'platinum standard' for quantitative urine and oral fluid toxicology, complemented by its CleanAssure dried blood spot offering built on Neoteryx's Volumetric Absorptive Microsampling (VAMS) technology—a first-mover integration in addiction recovery testing. Alcala has expanded its menu over time to include COVID-19 and respiratory pathogen testing (RT-PCR, SalivaDirect, IgG/IgM ELISA, and a 20-pathogen respiratory panel), standard blood wellness panels (male, female, chemistry, CBC, lipid, thyroid), and urinalysis, with toxicology panels offered in three tiers (Quick Study, Discover, Comprehensive) covering 230+ prescription medications and 30+ illicit drugs.

The business operates a direct B2B sales-led model, targeting healthcare providers through a two-person sales team and a web-based LIMSABC physician portal for requisition submission, accessioning tracking, and results review. Revenue is generated on a fee-for-service, per-test transaction basis, with pricing negotiated per client contract rather than publicly disclosed; billing cadence is monthly. Specimens are collected at client facilities and shipped overnight to the single San Diego laboratory. The company is founder-owned (President Matt Rifat is a healthcare attorney), privately held, CLIA-certified, and has been designated by Yale School of Public Health to perform SalivaDirect COVID-19 testing under FDA EUA. Its marketing is primarily digital (website, LinkedIn) supplemented by direct sales engagement and earned media, with no disclosed institutional funding, M&A activity, or geographic expansion outside the United States.

Name

Alcala

Legal name

Alcala Labs

Website

https://alcalalabs.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Alcala Labs is a San Diego-based clinical laboratory providing quantitative toxicology, CleanAssure dried blood spot testing, infectious disease, and blood wellness panels to drug rehabilitation facilities, pain management practices, and psychiatry practices on a fee-for-service basis.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Clinical laboratory testing
• Toxicology screening services
• Pharmacogenetic testing
• Infectious disease diagnostics
• Blood wellness panels

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Laboratory Testing Services: Alcala Labs generates revenue through fee-for-service laboratory testing across multiple specimen types (urine, oral fluid, dried blood spots, venous blood, saliva). Testing panels range from basic drug screening to comprehensive panels covering 230+ prescription medications and 30+ illicit drugs with metabolite confirmations. COVID-19 and respiratory pathogen testing is offered as an additional revenue stream. Revenue is derived from billable tests submitted by healthcare providers and facilities.
2. Specialized Diagnostic Panels: The company offers tiered testing panels (Quick Study, Discover, and Comprehensive) for toxicology, blood wellness, and infectious disease. Each panel tier covers different analytes and provides quantitative results. These panels are sold to physicians and addiction recovery facilities on a per-test basis.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Alcala Labs operates a CLIA-certified clinical laboratory providing quantitative toxicology, pharmacogenetic, blood wellness, and infectious disease diagnostic testing services. The company serves healthcare providers and facilities—primarily drug rehabilitation centers, pain management practices, and psychiatry practices—through LC-MS urine/oral fluid testing, CleanAssure VAMS dried blood spot testing, and COVID-19/respiratory pathogen testing panels. Specimens are collected at client sites and shipped to the San Diego laboratory for analysis, with results delivered via a web-based physician portal.

Product overview

Alcala Labs is a clinical laboratory providing specialized diagnostic testing services primarily for drug rehabilitation, pain management, and psychiatry practices. The company offers a portfolio of testing services organized around five core offerings: Toxicology Testing using LC-MS technology for urine and oral fluid specimens; CleanAssure™ dried blood spot testing using VAMS technology as a minimally invasive alternative; Infectious Disease Testing covering COVID-19 and respiratory pathogens; Blood Testing including male and female wellness panels; and Urinalysis validity testing. All toxicology services are available in three panel tiers (Quick Study, Discover, Comprehensive) enabling customizable testing depth. The Physician Portal provides web-based access to results and sample submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Toxicology Testing (Urine/Oral Fluid) Quantitative toxicology testing using liquid chromatography/mass spectrometry (LC-MS) for detection of drugs of abuse in urine and oral fluid specimens, with 24-hour turnaround and three panel tiers (Quick Study, Discover, Comprehensive) for healthcare providers.
• CleanAssure Toxicology testing using dried blood spot collections via the Mitra microsampling device with Volumetric Absorptive Microsampling (VAMS) technology, providing a minimally invasive finger-prick alternative to urine testing for monitoring patients in addiction recovery.
• Infectious Disease Testing Comprehensive COVID-19 and respiratory pathogen testing including SARS-CoV-2 RNA detection, antibody testing (IgG & IgM), and a 20-pathogen respiratory panel. Includes SalivaDirect RT-PCR, nasal swab, and serum ELISA testing methods.
• Blood Testing (Wellness Panels) Clinical laboratory blood testing including male and female wellness panels, chemistry profiles, complete blood count (CBC), metabolic panels, lipid profiles, thyroid panels, and specialized hematology assays.
• Urinalysis Testing Validity testing for detection and assessment of urinary tract infections, kidney disease, diabetes, and other disorders. Tests include glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, leukocytes, and specific gravity.
• Male Wellness Panel Comprehensive male health screening panel including cholesterol, CBC, CMP, lipid profile, ferritin, folate, insulin, testosterone, thyroid markers (TSH, T3, T4), and Vitamin B12.
• Female Wellness Panel Women's health screening panel including calcium, cholesterol, estradiol, and progesterone markers.
• Toxicology Analyte Panels Extended toxicology panel covering 230 prescription medications/drugs with 40 metabolite confirmations and 30 illicit drugs with 3 metabolite confirmations across 26 drug classes including opiates, benzodiazepines, antidepressants, stimulants, and synthetic cannabinoids.

Quantifiable outcome

• Over 200 unique compounds detected including latest synthetic drugs
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Neoteryx LLCcoreTechnology or Integration · 18 July 2018Neoteryx LLC supplies its Volumetric Absorptive Microsampling (VAMS) technology, in the form of the Mitra microsampling device, to Alcala Labs for use in the CleanAssure dried blood spot testing offering. Alcala Labs was the first lab to commercialize this technology for addiction recovery centers, enabling patients to collect samples via finger prick rather than urine collection. Samples are shipped directly to Alcala Labs for testing and results.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Precision Toxicology: Clinical toxicology laboratory providing drug monitoring and pain management testing for physicians and addiction treatment centers. Directly comparable to Alcala in service portfolio, target customer segments, and physician-office distribution model.
• Confirmatrix Laboratories: Toxicology and pain management laboratory offering LC-MS confirmation testing to physician practices. Comparable to Alcala in technology platform, customer focus, and emphasis on quantitative confirmatory drug testing.
• Millennium Health: Specialty toxicology laboratory focused on drug monitoring and pharmacogenetics, serving pain management, addiction treatment, and behavioral health providers. Direct competitor to Alcala's core LC-MS toxicology and CleanAssure offerings, with a similar physician-office GTM model.
• Avero Diagnostics: Specialty laboratory focused on pain management and behavioral health toxicology, providing urine drug monitoring and PGx testing to physician offices. Closely comparable to Alcala in niche focus, customer segments, and panel-based testing approach.
• Dominion Diagnostics: Specialty clinical toxicology and pharmacogenomics laboratory serving addiction treatment and pain management providers. Directly comparable to Alcala in service line, target customer base, and clinical LC-MS methodology.
• Aegis Sciences Corporation: Clinical forensic toxicology and pharmacogenetics laboratory that serves pain management, substance use disorder, and behavioral health prescribers. Closely comparable to Alcala in target customer base, LC-MS methodology, and emphasis on defensible quantitative results.
• Cordant Health Solutions: Specialty toxicology and medication monitoring laboratory serving addiction treatment, criminal justice, and pain management markets. Comparable to Alcala in LC-MS toxicology, behavioral health focus, and tamper-resistant specimen collection emphasis.

Broad incumbents

• Sonic Healthcare USA: International clinical laboratory operator with U.S. footprint in reference and esoteric testing, including toxicology and infectious disease. Overlaps with Alcala in clinical chemistry and specialty testing, but competes as a broad portfolio player rather than a niche specialist.
• Quest Diagnostics: Largest U.S. clinical laboratory offering toxicology, infectious disease, and routine diagnostics with national logistics and broad payer contracts. Competes with Alcala in physician toxicology and COVID-19 testing but as a generalist with portfolio breadth beyond Alcala's specialty focus.
• Laboratory Corporation of America (Labcorp): National clinical reference laboratory providing toxicology, infectious disease, and routine diagnostics to physician practices and health systems. Overlaps with Alcala in drug monitoring and COVID-19 testing, but operates at much greater scale and with integrated payer networks.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alcala-testing-and-analysis-services

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alcala